BB&T Corp decreased its stake in Cigna Corporation (NYSE:CI) by 7.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 6,173 shares of the health services provider’s stock after selling 478 shares during the period. BB&T Corp’s holdings in Cigna Corporation were worth $1,033,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also made changes to their positions in the company. BlackRock Inc. increased its position in Cigna Corporation by 2,335.5% in the first quarter. BlackRock Inc. now owns 16,987,425 shares of the health services provider’s stock valued at $2,488,489,000 after buying an additional 16,289,943 shares in the last quarter. Vanguard Group Inc. increased its position in Cigna Corporation by 3.5% in the first quarter. Vanguard Group Inc. now owns 16,706,266 shares of the health services provider’s stock valued at $2,447,301,000 after buying an additional 570,241 shares in the last quarter. State Street Corp increased its position in Cigna Corporation by 1.7% in the first quarter. State Street Corp now owns 11,137,018 shares of the health services provider’s stock valued at $1,631,451,000 after buying an additional 190,323 shares in the last quarter. Wellington Management Group LLP increased its position in Cigna Corporation by 9.3% in the first quarter. Wellington Management Group LLP now owns 10,765,751 shares of the health services provider’s stock valued at $1,577,075,000 after buying an additional 913,991 shares in the last quarter. Finally, Boston Partners increased its position in Cigna Corporation by 3.1% in the first quarter. Boston Partners now owns 3,604,693 shares of the health services provider’s stock valued at $528,052,000 after buying an additional 108,880 shares in the last quarter. 86.91% of the stock is owned by institutional investors and hedge funds.

Cigna Corporation (CI) opened at 172.55 on Monday. The firm has a market cap of $44.18 billion, a price-to-earnings ratio of 23.04 and a beta of 0.46. Cigna Corporation has a 52-week low of $115.03 and a 52-week high of $178.50. The firm’s 50-day moving average price is $170.76 and its 200 day moving average price is $157.68.

Cigna Corporation (NYSE:CI) last announced its quarterly earnings data on Friday, August 4th. The health services provider reported $2.91 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.48 by $0.43. Cigna Corporation had a return on equity of 17.58% and a net margin of 7.46%. The firm had revenue of $10.32 billion for the quarter, compared to analysts’ expectations of $10.26 billion. During the same quarter in the prior year, the firm posted $1.98 earnings per share. Cigna Corporation’s revenue for the quarter was up 3.6% compared to the same quarter last year. On average, equities research analysts forecast that Cigna Corporation will post $9.79 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another website, it was illegally copied and republished in violation of US & international copyright & trademark laws. The original version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/08/07/bbt-corp-reduces-stake-in-cigna-corporation-nyseci-updated.html.

Several research firms recently commented on CI. Jefferies Group LLC reissued a “buy” rating and issued a $190.00 price objective on shares of Cigna Corporation in a research note on Friday. Royal Bank Of Canada reaffirmed a “buy” rating and issued a $182.00 target price on shares of Cigna Corporation in a research note on Monday, July 24th. ValuEngine downgraded Cigna Corporation from a “buy” rating to a “hold” rating in a research note on Thursday, July 20th. BidaskClub downgraded Cigna Corporation from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Finally, Deutsche Bank AG raised their target price on Cigna Corporation from $175.00 to $180.00 and gave the company a “buy” rating in a report on Thursday, July 13th. Two equities research analysts have rated the stock with a hold rating and nineteen have given a buy rating to the company’s stock. Cigna Corporation currently has a consensus rating of “Buy” and an average target price of $177.17.

In other news, EVP Nicole S. Jones sold 20,312 shares of the stock in a transaction that occurred on Wednesday, May 17th. The stock was sold at an average price of $160.04, for a total transaction of $3,250,732.48. Following the sale, the executive vice president now directly owns 44,737 shares in the company, valued at approximately $7,159,709.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Mary T. Hoeltzel sold 500 shares of the stock in a transaction that occurred on Tuesday, June 6th. The stock was sold at an average price of $166.70, for a total value of $83,350.00. Following the sale, the vice president now owns 2,449 shares in the company, valued at $408,248.30. The disclosure for this sale can be found here. Insiders have sold 219,558 shares of company stock worth $37,135,665 in the last 90 days. 1.30% of the stock is currently owned by insiders.

Cigna Corporation Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Institutional Ownership by Quarter for Cigna Corporation (NYSE:CI)

Receive News & Stock Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related stocks with our FREE daily email newsletter.